Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Gilead Sciences
LEI 549300WTZWR07K8MNV44, SWIFT GILSUS6SXXX

Nom de l'organisation
Gilead Sciences Inc
Nom du pays
États-Unis
Pays d'enregistrement
États-Unis
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
22.250 millions USD

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company primary areas of focus include HIV, AIDS, liver disease, and serious cardiovascular and respiratory conditions.

Récompenses

Actualités

22/03/2024 Gilead Sciences: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
11/02/2024 Gilead Sciences: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibits
01/02/2024 Gilead Sciences: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
21/12/2023 S&P Global Ratings affirms Gilead Sciences at "BBB+" (Local Currency LT credit rating); outlook positive
21/12/2023 S&P Global Ratings affirms Gilead Sciences at "BBB+" (Foreign Currency LT credit rating); outlook positive
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
I q ang
II q ang
III q ang
IV q ang
2020
I q ang
II q ang
III q ang
IV q ang
2019
I q ang
II q ang
III q ang
IV q ang
2018
I q ang
II q ang
III q ang
IV q ang
2017
I q ang
II q ang
III q ang
IV q ang
2016
I q ang
II q ang
III q ang
IV q ang
2015
I q ang
II q ang
III q ang
IV q ang
2014
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • LEI
    549300WTZWR07K8MNV44
  • SWIFT
    GILSUS6SXXX
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0000882095
  • EIN
    94-3047598

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.